Skip to main navigation
Skip to main content
Skip to Footer
Global
Sandoz Site Directory
Our Work
What We Do
Disease Areas
Prescription Medicines
Over-The-Counter Medicines
Partnerships and Collaborations
Biopharmaceuticals
About Us
Who We Are
Corporate Responsibility
Doing Business Responsibly
Investor Information
Contact Us
Diversity & Inclusion
News
All News
Media Releases
Publications
Media Library
Stay Up-To-Date
Media Contacts
Careers
Job Search
Working at Sandoz
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2016
November
Media Release
/
Nov 22, 2016
Sandoz to donate up to USD 10 million of high-quality generic medicines annually to Americares to increase access to medicines
Read More
Media Release
/
Nov 18, 2016
Innovative study with three treatment switches confirms Sandoz biosimilar etanercept has equivalent efficacy to originator
Read More
October
Media Release
/
Oct 25, 2016
Novartis delivered solid third quarter with Growth Products[1] offsetting Gleevec patent expiration; several positive readouts for potential blockbusters
Read More
September
Media Release
/
Sep 28, 2016
Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve healthcare access challenges
Read More
Media Release
/
Sep 16, 2016
Top-line results for PF-06438179 (biosimilar infliximab) demonstrate equivalent efficacy to reference product
Read More
August
Media Release
/
Aug 31, 2016
AirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to treatment
Read More
Media Release
/
Aug 30, 2016
FDA approves Sandoz Erelzi™ to treat multiple inflammatory diseases
Read More
Media Release
/
Aug 18, 2016
Launch of novel on-demand news service Transplant TODAY from TTS 2016 transplant congress
Read More
July
Media Release
/
Jul 19, 2016
Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects
Read More
Media Release
/
Jul 13, 2016
Sandoz biosimilar etanercept recommended by FDA advisory committee for approval to treat multiple inflammatory diseases
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
…
Page
12
of 5
Page
13
of 5
Current page
14
of 5
Page
15
of 5
Page
16
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Whatsapp
Jump to Comments
Print
Save
You are here
Home
›
News
›